rs2226628: Understanding This Genetic Variant and IBD Research
The genetic variant rs2226628 is a single nucleotide polymorphism located in an intergenic region on chromosome 11. It has been investigated in scientific literature for its potential association with the risk of developing inflammatory bowel disease (IBD).
What each genotype means
Typical genetic profile
This genotype represents the most common form of this variant observed in many populations. Current large-scale research studies have not established a significant or consistent association between this specific genetic marker and an increased risk of inflammatory bowel disease.
This is the most frequently observed genotype across most studied ancestral groups.
Typical genetic profile
This genotype represents a common variation at this location. Large-scale genetic association studies have failed to find evidence that this specific marker significantly influences the risk of developing inflammatory bowel disease.
This genotype is found at varying frequencies depending on ancestral background, but is generally common.
Typical genetic profile
This genotype is a common variation at this site. Scientific literature indicates that this variant does not reach the threshold for being considered a significant genetic risk factor for inflammatory bowel disease in major population studies.
This genotype is observed in a significant portion of the population, with frequencies varying by ancestry.
What is rs2226628?
The variant rs2226628 is a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. This specific SNP is located in an intergenic region on chromosome 11. Intergenic regions are segments of DNA that lie between genes; while they do not code for proteins directly, they often contain regulatory elements that can influence how nearby genes are expressed. Because this variant is not located within a gene, researchers study it to determine if it acts as a marker for nearby functional changes or if it plays a role in the complex regulatory networks that govern immune system activity in the gut.
Research and IBD Associations
Inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis, is a complex, immune-mediated disorder. Over the past two decades, genome-wide association studies (GWAS) have identified hundreds of genetic loci associated with IBD risk. The variant rs2226628 has been included in various association analyses investigating these susceptibility loci. However, the evidence for this specific variant is mixed. While some studies have explored its potential link to IBD, subsequent large-scale analyses have sometimes failed to find consistent or strong evidence of association, particularly in European cohorts. This highlights the complexity of IBD genetics, where many variants have small effect sizes and may only show significance in specific ancestral populations or very large sample sizes.
Population Frequency and Ancestry
Genetic variants often show significant differences in frequency across different ancestral populations. Research indicates that the frequency of rs2226628 varies notably between groups. For instance, some studies have reported a much lower minor allele frequency in individuals of European descent compared to those of East Asian descent. Because rare alleles are more likely to be population-specific, these differences are critical for researchers to consider when interpreting GWAS results. Understanding these frequency disparities is essential for the field of trans-ancestry genetics, which aims to move beyond European-centric data to better understand the genetic architecture of complex diseases across all human populations.
Interpreting Genetic Information
It is important to understand that having a specific genotype for a variant like rs2226628 does not constitute a medical diagnosis. IBD is a multifactorial condition influenced by a combination of genetics, environmental factors, and the gut microbiome. Most genetic variants identified in GWAS have only a modest impact on overall disease risk. Consequently, this information cannot be used to predict whether an individual will develop IBD. If you have concerns about your digestive health or family history, the most appropriate step is to consult with a healthcare professional, such as a gastroenterologist, who can evaluate your symptoms and clinical history rather than relying on individual genetic markers.
How common is this variant?
The frequency of the rs2226628 variant varies significantly by ancestry, with reported minor allele frequencies being much lower in European populations compared to East Asian populations.
Frequently asked questions
Does having the rs2226628 variant mean I will get IBD?
No. Genetic variants associated with IBD only represent a small fraction of the overall risk. Most people with these variants never develop the disease, as it is influenced by many other genetic and environmental factors.
Where can I find more information on IBD genetics?
You can explore resources like the GWAS Catalog or MedlinePlus Genetics for broad information on how genetic research is used to study complex diseases like IBD.
Should I get tested for this SNP?
There is no clinical utility in testing for this specific SNP. It is a research-grade marker and is not used in standard medical practice to diagnose or manage inflammatory bowel disease.
Why do studies show different results for this variant?
Different studies may use different populations, sample sizes, and statistical methods. In complex diseases, it is common for initial findings to be refined or not replicated as research cohorts grow larger and more diverse.
Sources & further reading
Educational information only, last refreshed 10/31/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2226628?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is associated with body fat percentage and shows a significant correlation with earlier age at menarche.
This variant is associated with Alzheimer's disease risk and may impact cognitive performance through its influence on the PAK5 gene.
This European-specific variant is associated with multiple sclerosis risk, though its functional mechanism in non-coding regions remains under investigation.
This variant in the PAM gene is associated with an increased risk of type 2 diabetes mellitus in the Chinese population.
This variant in the CASP3 gene is associated with susceptibility to prostate cancer and adverse clinical outcomes.
This variant in the CASP9 gene is identified as a candidate marker for prostate cancer susceptibility.
